Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleHuman Studies

Treatment of Metastatic Prostate Carcinoma with Radiolabeled Antibody CC49

Ruby F. Meredith, Anton J. Bueschen, M.B. Khazaeli, Walter E. Plott, William E. Grizzle, Richard H. Wheeler, Jeffrey Schlom, Charles D. Russell, Tiepu Liu and Albert F. LoBuglio
Journal of Nuclear Medicine June 1994, 35 (6) 1017-1022;
Ruby F. Meredith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anton J. Bueschen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.B. Khazaeli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter E. Plott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William E. Grizzle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard H. Wheeler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Schlom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles D. Russell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiepu Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert F. LoBuglio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 35, Issue 6
June 1, 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Treatment of Metastatic Prostate Carcinoma with Radiolabeled Antibody CC49
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Treatment of Metastatic Prostate Carcinoma with Radiolabeled Antibody CC49
Ruby F. Meredith, Anton J. Bueschen, M.B. Khazaeli, Walter E. Plott, William E. Grizzle, Richard H. Wheeler, Jeffrey Schlom, Charles D. Russell, Tiepu Liu, Albert F. LoBuglio
Journal of Nuclear Medicine Jun 1994, 35 (6) 1017-1022;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Treatment of Metastatic Prostate Carcinoma with Radiolabeled Antibody CC49
Ruby F. Meredith, Anton J. Bueschen, M.B. Khazaeli, Walter E. Plott, William E. Grizzle, Richard H. Wheeler, Jeffrey Schlom, Charles D. Russell, Tiepu Liu, Albert F. LoBuglio
Journal of Nuclear Medicine Jun 1994, 35 (6) 1017-1022;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Targeting cancer-associated glycosylation for adoptive T cell therapy of gastro-intestinal and gynecological cancers
  • Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
  • Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus177Lu-DOTA-PESIN)
  • Monodispersed DOTA-PEG-Conjugated Anti-TAG-72 Diabody Has Low Kidney Uptake and High Tumor-to-Blood Ratios Resulting in Improved 64Cu PET
  • Impact of Rituximab Treatment on 90Y-Ibritumomab Dosimetry for Patients with Non-Hodgkin Lymphoma
  • Emerging Role of Platelet-Derived Growth Factor Receptor-{beta} Inhibition in Radioimmunotherapy of Experimental Pancreatic Cancer
  • Intraperitoneal Pretarget Radioimmunotherapy with CC49 Fusion Protein
  • Current Status of Therapy of Solid Tumors
  • A Phase I Trial of 90Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer
  • In Vitro Affinity Maturation of a Specificity-Determining Region-Grafted Humanized Anticarcinoma Antibody: Isolation and Characterization of Minimally Immunogenic High-Affinity Variants
  • Enhanced Therapeutic Index of Radioimmunotherapy (RIT) in Prostate Cancer Patients: Comparison of Radiation Dosimetry for 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-Tetraacetic Acid (DOTA)-Peptide versus 2IT-DOTA Monoclonal Antibody Linkage for RIT
  • Improved Prediction of Myelotoxicity Using a Patient-Specific Imaging Dose Estimate for Non-Marrow-Targeting 90Y-Antibody Therapy
  • Targeted Therapy of Cancer with Radiolabeled Antibodies
  • Radioimmunotherapy with 111In/90Y-2IT-BAD-m170 for Metastatic Prostate Cancer
  • An {{alpha}}-Particle Emitting Antibody ([213Bi]J591) for Radioimmunotherapy of Prostate Cancer
  • Optimizing the Sequence of Combination Therapy with Radiolabeled Antibodies and Fractionated External Beam
  • In Vitro Characterization of Radiolabeled Monoclonal Antibodies Specific for the Extracellular Domain of Prostate-specific Membrane Antigen
  • High-Dose Therapy with 90Yttrium-labeled Monoclonal Antibody CC49: A Phase I Trial
  • Imaging and Phase I Study of 111In- and 90Y-labeled Anti-LewisY Monoclonal Antibody B3
  • Structural Correlates of an Anticarcinoma Antibody: Identification of Specificity-Determining Residues (SDRs) and Development of a Minimally Immunogenic Antibody Variant by Retention of SDRs Only
  • Google Scholar

More in this TOC Section

  • Photopenia in Chronic Vertebral Osteomyelitis with Technetium-99m-Antigranulocyte Antibody (BW 250/183)
  • Changes in Results of Gallium-67-Citrate Scanning after Interferon Therapy for Chronic Hepatitis C
  • Characterization of Pulmonary and Myocardial Beta-Adrenoceptors with S-1′-[Fluorine-18]Fluorocarazolol
Show more Human Studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire